Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Pilot Study of Ustekinumab for Subjects With Chronic Atopic Dermatitis

This study is ongoing, but not recruiting participants.
Sponsor:
Information provided by (Responsible Party):
Rockefeller University
ClinicalTrials.gov Identifier:
NCT01806662
First received: February 28, 2013
Last updated: April 28, 2016
Last verified: April 2016
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is ongoing, but not recruiting participants.
  Estimated Study Completion Date: March 2018
  Estimated Primary Completion Date: March 2018 (Final data collection date for primary outcome measure)